Mirena®

DEVICE3 trials

Sponsors

FHI 360, Chang Gung Memorial Hospital, West China Second University Hospital

Conditions

Atypical Endometrial HyperplasiaContraceptionEndometrial Cancer

Phase 2

Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer

Chang Gung Memorial HospitalEndometrial Cancer

Start: 2016-03-31End: 2020-03-31Updated: 2016-12-13

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

RecruitingNCT03463252

West China Second University HospitalAtypical Endometrial Hyperplasia, Endometrial Cancer

Start: 2018-04-01End: 2030-12-30Target: 224Updated: 2021-09-13

Phase 4

Long-Acting Reversible Contraception

CompletedNCT01299116

FHI 360Contraception

Start: 2011-12-31End: 2016-12-31Updated: 2018-02-28

Related Papers

Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)

BMJ Open2020-02-0133 citations